--------------------------------------------------------------------------------

 

Exhibit 10.1

CONFIDENTIAL

DISTRIBUTION AGREEMENT

This Distribution Agreement ("Agreement") is made as of this 30th day of
September, 2009, by and between: MICRUS ENDOVASCULAR CORPORATION, a corporation
organized under the laws of Delaware, having its principal place of business at
821 Fox Lane, San Jose, California ("Micrus") and IDS （Hong Kong） Ltd.  company
organized under the laws of Hong Kong and having a principal place of business
at   14/F Li Fung Center, 2 On Ping Street， Siu Lek Yuan, Shatin, Hong Kong
(“Distributor”)

WHEREAS, Micrus has developed and/or commercialized Products (as hereinafter
defined) to be used in the Field (as hereinafter defined), and may develop other
products for use in the Field; and

WHEREAS, Distributor has substantial experience in marketing medical products
and desires to distribute the Products, as hereinafter defined, in the
territories of  Hong Kong and China; and
 
WHEREAS, Micrus is willing to use Distributor as its exclusive distributor of
the Products for use in the Field, in the territory of Hong
Kong and China  subject to the terms and conditions of this Agreement.

NOW THEREFORE, in consideration of the premises and the mutual covenants herein
recited, and other good and valuable considerations, the receipt of which is
acknowledged, it is agreed as follows:

ARTICLE I - DEFINITIONS

As used in this Agreement, the following terms, whether used in the singular or
plural, shall have the meanings indicated:

 
1.1   "Effective Date" shall mean the date of this Agreement first written
above.

1.2   "Field" shall mean the field of interventional neuroradiology, or such
field(s) as to which the parties may agree in writing.

1.3  "Marketing Authorizations" shall mean all authorizations, licenses,
approvals, and registrations to import, market and distribute the Products in
the Territory pursuant to the terms of this Agreement, as may be required by an
appropriate governmental agency in the Territory, except any CE Mark, which such
mark shall be obtained and maintained by Micrus.

1.4   "Product(s)" shall mean the Micrus products which are listed on Exhibit A
hereto (either at the Effective Date or thereafter by mutual agreement of the
parties), solely as used in the Field and as delivered to Distributor from time
to time by Micrus under this Agreement.

1.5   “Territory” shall mean the geographic territory(ies) of Hong Kong and
China .

ARTICLE II - APPOINTMENT OF DISTRIBUTOR

2.1           Appointment of Distributor.  Subject to the terms and conditions
of this Agreement (including, without limitation, Article 6), Micrus hereby
appoints Distributor as Micrus’ exclusive distributor of the Products within the
Territory.  Distributor agrees that it shall not sell, advertise, distribute or
otherwise transfer or assist in the transfer of any product that competes with
any Product.  Distributor may distribute the Products only as packaged by
Micrus.  It is understood, however, that if Distributor believes that any such
packaging would not be in conformity with requirements of relevant authorities
in the Territory, Distributor will immediately bring this to Micrus'
attention.  Distributor shall not sell, advertise, distribute, or otherwise
transfer or assist in the transfer of any Product outside the Territory or to
persons or entities located outside the Territory.  Micrus reserves the right to
grant similar distribution rights in the Products to third parties for
distribution and sale outside of the Territory; provided, however, such third
parties shall be similarly required to agree not to sell, advertise, distribute,
or otherwise transfer or assist in the transfer of the Products
 

***Certain confidential information contained in this document, marked by
brackets, has been omitted and filed with the Securities and Exchange Commission
pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
1

--------------------------------------------------------------------------------

 

in the Territory or to persons or entities located in the Territory during the
term of this Agreement.  Distributor may appoint sub-distributors of the
Products, provided that (a) prior to each such appointment, Distributor shall
have conducted a reasonable background check with respect to the subdistributor
and shall have reasonably determined that the subdistributor and its owners,
managers and employees have not been charged with or convicted of any
misconducts or criminal activity, have a good reputation,  have adequate skills
and experience to sell and support products for neurointerventional procedures,
and do not have a family or business relationship with any hospital or
government official or employee that could result in any such official or
employee receiving a financial benefit from sales of Products by such subagent;
(b) Distributor shall have entered a binding written agreement with each such
subdistributor containing provisions reasonably calculated to ensure compliance
with Distributor’s obligations hereunder, including without limitation the
provisions of Section 5.5 hereof, and expressly prohibiting the appointment by
the subdistributor of any subdistributors or subagents; (c) Distributor shall
provide written notice to Micrus in the English language identifying each
subdistributor appointed hereunder, including the name, address, phone number
and authorized representative(s) of such subdistributor.   Any such appointment
shall not relieve Distributor of its obligations hereunder, and Distributor
shall be responsible to Micrus for any act or omission of a subdistributor that
would, if committed by Distributor, constitute a breach of this Agreement.
 
2.2      Relationship of Parties.  The relationship of Micrus and Distributor
established by this Agreement is that of independent contractors, and nothing
contained in this Agreement shall be construed to:  (i) give either party the
power to direct or control the day-to-day activities of the other; or (ii) allow
Distributor to create or assume any obligation on behalf of Micrus for any
purpose whatsoever.  All financial obligations associated with Distributor
business are the sole responsibility of Distributor.  All sales and other
agreements between Distributor and its customers are Distributor's exclusive
responsibility and shall impose no duty or obligation upon Micrus and shall not
have the effect of lessening any of Distributor's obligations under this
Agreement.
 
2.3      Marketing Authorizations.
 
2.3.1           Micrus Obligations.  Micrus shall deliver to Distributor all
scientific, clinical, toxicological, and manufacturing data in the possession of
Micrus, to the extent necessary for Distributor to obtain all required Marketing
Authorizations within the Territory, provided Distributor maintains all such
data as confidential pursuant to Article VII.  At its own expenses, Micrus shall
be responsible for product registration in the Territory.
 
2.3.2           Distributor Obligations. At its own expense, Distributor shall
use its best efforts to obtain and maintain all necessary Marketing
Authorizations within the Territory, except for the product
registration.  Specifically, Distributor agrees that it will undertake to
manage, at Distributor's expense, all animal trials and human clinical trials
required to obtain the Marketing Authorizations.  These approvals will be
obtained in the name of Micrus,  with Distributor as agent of Micrus for the
purpose of such Marketing Authorizations.  Upon termination of this Agreement,
Distributor agrees to transfer all of its rights, title and interest, if any, in
and to such approvals to Micrus, or any third party as may be designated in
writing by Micrus.  Distributor shall provide Micrus with written monthly
progress reports of its efforts to obtain Marketing Authorizations.  Distributor
agrees not to sell or distribute any Product in any geographic region within the
Territory until such time as all Marketing Authorizations in such geographic
region have duly been obtained, and to act at all times in a manner consistent
with such Marketing Authorizations.
 
2.3.3           Distributor Qualifications. Distributor warrants that it has,
and complies with all requirements of, all necessary licenses, approvals and/or
qualifications as required under the applicable laws of the Territory,
regulations and rules to enter into this Agreement and to distribute the
Products in the Territory.  Any discontinuance of such licenses, approvals, or
qualifications, or of Distributor's compliance with such requirements, shall be
deemed a material breach of this Agreement.
 
2.4      Trademarks
 
2.4.1           License.  Micrus hereby grants to Distributor the
non-transferable, non-assignable, non-sublicensable right and license to use the
trademarks, service marks, and trade names that Micrus may adopt from time to
time in connection with Products sold hereunder (the "Trademarks") solely on or
in connection with Distributor's promotion, sale and distribution of the
Products within the Territory as authorized under this Agreement for the term of
this Agreement.  Distributor shall have the right to indicate to the public that
it is an authorized distributor of the Product.  Distributor shall not alter or
remove any Trademark applied to the Product.  Nothing herein shall grant to
Distributor any right, title or interest in the Trademarks.  All use of the
Trademarks, and goodwill associated therewith, shall inure to the benefit of
Micrus.  At no time during or after the term of this Agreement shall Distributor
challenge or assist others to challenge the Trademarks or the registration
thereof or attempt to register any trademarks, marks or trade names confusingly
similar to those of Micrus.
 

 
 
2

--------------------------------------------------------------------------------

 

2.4.2           Approval of Representations.  Distributor shall respect the
Trademarks and follow the instructions of Micrus as to all usage of the
Trademarks, including, without, limitation, complying with Micrus' quality
control requirements and submitting samples of Distributor's use of the
Trademarks to Micrus for approval.  If any of the Trademarks are to be used in
conjunction with any other mark on or in relation to the Product, then the
Trademark shall be presented equally legibly, equally prominently, and of the
same or greater size than the other mark(s) but nevertheless separated from the
other trademark so that each appears to be a mark in its own right, distinct
from the other mark(s).
 
2.5           Provision of Data. Distributor agrees to provide Micrus promptly
with all clinical and technical information and data with respect to the
Products which it develops during the term of this Agreement. Distributor
further agrees to communicate promptly to Micrus any and all modifications,
design changes or improvements to the Products suggested by any of Distributor's
customers, distributors, employees or agents. Distributor further agrees that
Micrus shall have, and is hereby assigned, any and all right, title and interest
in and to any such suggested modifications, design changes or improvements to
the Products without the payment of any additional consideration therefore
either to Distributor or its customers, distributors, employees or agents.
Distributor will also promptly notify Micrus of any infringement of any of the
Trademarks, patent or other proprietary rights relating to the Products of which
Distributor becomes aware.
 
2.6           Protection Of Legends.  Distributor shall not remove, overprint or
deface any notice of confidentiality, patent numbers, patent pending notice,
copyright, trademark, logo, legend or other notices of ownership or
confidentiality from any originals or copies of any materials, goods or products
it obtains from Micrus.

2.7           Reverse Engineering.  Distributor shall not, by itself or through
its agents or a third party, reverse-engineer, de-compile, or disassemble any
device or technology disclosed to it under this Agreement.

ARTICLE III  - PURCHASE OF PRODUCT

3.1  Terms and Conditions. All purchases of Products by Distributor from Micrus
during the term of this Agreement shall be subject to the terms and conditions
of this Agreement.

3.2  Prices.

3.2.1 Subject to this Section 3.2, Micrus will sell Products to Distributor at
the preferential prices shown in Exhibit A ("Purchase Price") until [***] after
the Effective Date.  Thereafter, Micrus may at any time change the prices for
Products upon 120 days’ advance written notice to Distributor, and such prices
shall supersede the prices set forth in Exhibit A (or any prior notice of
pricing) and shall become part of this Agreement. The differences between the
Purchase Price and Distributor's selling price to its customers shall be
Distributor's sole remuneration for sale of the Product. Distributor shall have
sole discretion to establish the resale price of the Product to third parties
subject only to any regulatory or governmental limitations.

3.2.2 The Purchase Price can be revised [***] in writing through consultation
between Micrus and Distributor on [***], and at such other times as the parties
may agree in writing. Such revisions shall apply to all orders for the affected
Product received after the effective date of revision. Price increases shall not
affect unfulfilled purchase orders accepted by Micrus in writing prior to the
effective date of the price increase.

3.2.3 All prices are C.I.P. Hong Kong and China.

3.3   Taxes. The Purchase Price will be net of any Distributor federal, state or
local taxes that may be applicable to the Product. When Micrus has the legal
obligation to collect such taxes, the appropriate amount shall be added to
Distributor's invoice and paid by Distributor, unless Distributor provides
Micrus with a valid tax exemption certificate authorized by the appropriate
taxing authority.

3.4   Order and Acceptance.  All orders for Products submitted by Distributor
shall be initiated by written purchase orders sent to Micrus via a fax, e-mail,
or a method set forth in Section 11.5 and requesting a delivery date during the
term of this Agreement.  To facilitate Micrus' production scheduling,
Distributor shall submit purchase orders to Micrus at least ninety (90) days
prior to the first day of the requested month of delivery. No order shall be
binding upon Micrus until accepted by Micrus in writing, and Micrus shall have
no liability to Distributor with respect to purchase orders that are not so
accepted. Micrus shall either:  (i) notify Distributor, in writing (via any of
the means referenced above), of the acceptance or rejection of an order (or any
portion thereof) and of the assigned delivery date for accepted orders with ten
(10) days of receipt of the purchase order; or (ii) send Products pursuant to
such accepted
 

                       
*** Confidential Treatment Requested

 
3

--------------------------------------------------------------------------------

 

order.  No partial fulfillment of an order shall constitute a commitment to
fulfill the entire order, absent the written acceptance of such entire
order.  Micrus shall use its commercially reasonable efforts to deliver Products
at the time specified in its written acceptance of Distributor's purchase
orders. Micrus reserves the right, by giving  90 days’ advance written notice to
Distributor, to discontinue the manufacture, supply or sale of any Product, to
make changes in materials or design, or to add improvements to any Product.
 
3.5   Terms of Purchase Orders. Distributor's purchase orders submitted to
Micrus from time to time with respect to Products to be purchased hereunder
shall be governed by the terms of this Agreement, and nothing contained in any
such purchase order shall in any way modify such terms of purchase or add any
additional terms or conditions.

3.6   Payment. .  Micrus shall submit an invoice to Distributor upon each
shipment of Products ordered by Distributor. The invoice shall set forth the
Purchase Price for the Products  in a given shipment plus any taxes or other
applicable costs initially paid by Micrus but to be borne by Distributor.
Payment shall be made by Distributor by wire transfer.  For the initial order
hereunder to be placed upon approval of the products by the SFDA, terms will be
fifty percent (50%) of the aggregate purchase price for such order up front,
with the balance payable within  120) days of the invoice.  Thereafter, payment
terms shall be the full invoiced amount to be paid by Distributor to Micrus
within  (90) days of the date of the invoice. Any invoiced amount not received
within  (90) days of the date of invoice shall be subject to a service charge of
half percent (0.5%) per month, or if lower, the maximum interest rate allowed by
law. Distributor shall pay all of Micrus' costs and expenses (including
reasonable attorney's fees) to enforce and preserve Micrus' rights under this
Subsection 3.6.  Micrus shall not be obliged to ship Products hereunder at any
time when the outstanding balance for Products ordered by Distributor is equal
to or more than [***], or to ship Products that will (when shipped) result in an
outstanding balance of [***] or more.  In addition, if at any time an
outstanding invoice for Products shipped to Distributor becomes unpaid and
outstanding for greater than (30) days, at Micrus' option, Micrus may require
that Distributor effect payment by means of an irrevocable letter of credit
drawn on a California bank approved by Micrus; the letter of credit shall be
upon terms acceptable by Micrus, shall allow for partial shipment, and shall be
in an amount equal to Distributor's purchase price for the Products plus all
applicable taxes and other charges to be borne by Distributor. All exchange,
interest, banking collection and other charges shall be at Distributor's
expense.   Micrus may modify the credit limit amount or the maximum days to
payment set forth in this Section 3.6 as mutually agreed by the two parties in
good faith.   In addition, Micrus agrees to review these terms with Distributor
on the first anniversary of the Effective Date.

3.7     Monthly Reports. Within ten (10) days after the end of each calendar
month, Distributor shall provide Micrus with a written sales breakdown,
including without limitation, the amount and type of Product, and names of end
users of the Products sold in each country of the Territory during the period,
as well as a nonbinding forecast (by country) for the subsequent three-month
period

ARTICLE IV - SUPPLY OF PRODUCT

4.1     Terms of Distributor Requirements. Subject to the terms and conditions
of this Agreement (including, without limitation, Section 3.4), Micrus agrees to
sell and Distributor agrees to purchase from Micrus Distributor's entire
requirements of products of the type provided by Micrus under this Agreement,
solely for distribution and/or sale in the Territory. Micrus shall use
commercially reasonable efforts to manufacture the Products and, subject to
Section 3.4, supply them to Distributor in quantities sufficient to satisfy
Distributor's needs in accordance with the provisions of this Article IV,
provided Distributor submits to Micrus purchase estimates pursuant to Section
4.2.

4.2     Purchase Estimates. Distributor shall submit to Micrus, beginning ninety
(90) days before the first anticipated order of Products and within the first
ten (10) days after the beginning of each calendar quarter thereafter, a
non-binding good faith estimate of the amount of Products to be required and
purchased by Distributor for both the next three months and the next
twelve-month periods.

4.3     Inspection and Dispute Resolution Relating to Satisfaction of Product
Specifications. The following provisions relate to inspection and resolution of
disputes:

4.3.1 Rejection of Product. Distributor shall inspect all Products promptly upon
receipt thereof and may reject any Products pursuant to this Section 4.3.1 that
fails to meet the specifications set forth in Micrus' current product
specifications for the Product. Any Product not properly rejected within thirty
(30) days of receipt of that Product at Distributor's facility after customs
clearance for import (the "Rejection Period") shall be deemed accepted. To
reject a Product, Distributor shall within the Rejection Period, (i) notify
Micrus in writing of its rejection and the reason for the rejection, and (ii)
return, at its expense, the rejected Product to Micrus (the "Returned Product")
in the same condition in which it was delivered to Distributor. All claims made
by Distributor after its inspection of the Products shall be handled on a
case-by-case basis during which time Micrus shall have the right to first
inspect any Products

 
*** Confidential Treatment Requested

 
4

--------------------------------------------------------------------------------

 

involved before being required to take any action with respect thereto. Micrus
shall make its investigation within thirty (30) days of receipt of notice of a
claim from Distributor. Micrus shall, at its expense, replace Products it
determines to be defective and ship such replacement Products freight prepaid
and reimburse Distributor the Duty, VAT and any other direct expenses associated
with the returned Products. In no event shall Micrus be liable under this
Agreement for any failure of any Product to meet the specifications due to
modification or improper use, storage or shipment of the Product by Distributor
or anyone receiving the Product from or on behalf of Distributor.

4.3.2 Resolution of Disputes Relating to Product Specifications. If the parties
hereto fail to agree as to whether a delivered quantity of Product meets its
agreed specifications, then the parties shall cooperate to have the Product in
dispute analyzed by a jointly selected qualified independent testing laboratory.

4.3.3 Return of Product After Rejection Period. After the Rejection Period,
Micrus' limited warranty as stated in Section 8.1 hereof shall be applied. If
Micrus tests and inspects the Returned Product and determines that such Returned
Product (i) has been physically damaged by Distributor or anyone receiving the
product from or on behalf of Distributor, (ii) has been modified or improperly
used, stored or shipped by Distributor or anyone receiving the Product from or
on behalf of Distributor, or (iii) performs according to Micrus' written
specifications, no credit will be given to Distributor. If upon such test and
inspections such Returned Product (a) has not been physically damaged, (b) has
not been modified or improperly used, stored or shipped by Distributor or anyone
receiving the Product from or on behalf of Distributor, and (c) does not perform
to Micrus' written specification, these Returned Products will be replaced at no
cost to Distributor. In all cases of physical damage or modification to, or
improper use, storage or shipment of, Returned Product, no credit will be given
to Distributor.

4.4   Title. Title and risk of loss pass to Distributor  when Micrus delivers
the Product to its carrier at Micrus facility  . Micrus shall pay freight and
shipping insurance, and Distributor shall be solely responsible for the payment
of all other costs, expenses, fees, duties, imports, and charges of whatever
kind or nature arising from the shipment, delivery, and importation of Products
into the Territory. Distributor shall solely be responsible for taking all
actions necessary to obtain clearance to import Products into the Territory and
Distributor warrants that it will comply in all respects with any restrictions
set forth in the import and/or export license for every Product purchased
hereunder.

4.5   Reporting. Distributor agrees to report to Micrus any information from any
source, including, without limitation, employees, distributors, agents,
customers, user facilities, individuals, or medical or scientific literature,
whether published or unpublished, that reasonably suggests that there is a
problem with the Product or a probability that the Product or a similar product
has caused or contributed to a death, serious illness or serious injury,
including but not limited to, severe or permanent disability, stroke, or brain
damage as promptly as possible but within five (5) days of receipt of
information of such event. Distributor agrees not to disclose any such
information referred to herein to any third party without the prior written
consent of Micrus.

4.5.1 Serious illness means an event that is life threatening, results in
permanent impairment of a body function or permanent damage to the body
structure, or necessitates immediate medical or surgical intervention to
preclude permanent impairment of a body function or permanent damage to a body
structure.

4.5.2 Serious injury means an event that is life threatening, results in
permanent impairment of a body function or permanent damage to a body structure,
or necessitates medical or surgical intervention to preclude permanent
impairment of a body function or permanent damage to a body structure.

4.6   Monitoring. Each of the parties hereto shall monitor all relevant journals
and media communications for information on factors materially affecting the use
or efficacy of the Products and shall promptly inform the other party of such
information. The informing party may provide in writing its evaluation of such
information. Either party shall promptly inform the other if it has actual
knowledge of any measures which are necessary to eliminate or minimize any risk
associated with the use of the Products or a specific production lot of the
Product.

ARTICLE V - ADDITIONAL OBLIGATIONS OF DISTRIBUTOR

5.1   Marketing Obligations. Distributor agrees to use its best efforts to
successfully promote and distribute the Product, at its own expense, in the
Territory  using diligent and vigorous efforts to maximize sales and market
penetration at the earliest date. Such efforts shall include, but are not
limited to, preparing promotional materials, advertising the Products in trade
publications within the Territory, participating in appropriate trade shows
within the Territory, and directly soliciting orders from customers within the

 

 
5

--------------------------------------------------------------------------------

 

Territory for the Product. Subject to Micrus' approval and obligations under
Article VIII hereof, Distributor shall also be responsible for all quality
control, lot release for Distributor's requirements, promotional activities,
marketing and selling efforts, distribution and technical services. All
promotional materials developed by Distributor shall be submitted to Micrus for
approval before such materials are distributed by Distributor. Micrus shall
promptly review such materials, and if no written response is provided by Micrus
within thirty (30) days after receipt of such material, then the material will
be deemed to have been approved by Micrus.

5.2   Finances and Personnel. Distributor shall: (i) employ on its own behalf an
appropriate number of specialized, trained, and qualified sales personnel whose
main function shall be the promotion and sale of the Products in the Territory;
and (ii) maintain a suitable organization for the promotion and sale of the
Products in the Territory pursuant to Distributor's obligations hereunder.  The
foregoing obligations of Distributor shall be at Distributor’s sole cost,
expense and risk, provided that Micrus agrees to provided limited financial
support as described in Exhibit B or as otherwise agreed to in writing by the
parties from time to time.

5.3    Customer and Sales Reporting. Distributor shall, at its own expense and
consistent with the sales policies of Micrus:

5.3.1 place the Products in Distributor's catalogues as soon as possible and
feature the Products in any applicable trade show within the Territory that it
attends;

5.3.2 provide adequate contact with existing and potential customers within the
Territory on a regular basis, consistent with good business practice;

5.3.3 assist Micrus in assessing customer requirements for the Product,
including modifications and improvements thereto, in terms of quality, design,
functional capability, and other features; and

5.3.4 submit market research information, as reasonably requested by Micrus
regarding competition and changes in the market within the Territory.

5.4   Marketing Plans. Distributor shall submit to Micrus for its approval a
Product launch plan for the Products in the Territory on or before the obtaining
of product registration certificate and on or before  February 1 of each year
thereafter, an annual marketing and sales plan for the Product, Each of these
plans shall include specific marketing sales strategies, tactics and goals,
market research analysis, promotion budgets, and sales projections.

5.5   Compliance with Laws. Distributor shall market and distribute the Products
in the Territory in compliance with all applicable laws and regulations and good
commercial practice and for uses and applications approved by Micrus in writing
for the Product.  Distributor shall comply with all laws, rules and regulations
as applicable to the marketing, distribution and sale of the Products in the
Territory or any part of it.   Distributor further agrees to comply with the
U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”) and all
applicable export laws, restrictions and regulations of any U.S. or foreign
agency or authority and not to export or re-export or allow the export or
re-export of the Products or any related technology or information in violation
of any such laws, restrictions or regulations.  A copy of the FCPA is attached
to this Agreement as Exhibit C.

Distributor hereby declares that it has read and understood the provisions of
the FCPA and, on that basis, it further represents and covenants that neither it
nor any of its employees or agents have taken or will take any action to cause
Distributor to be in violation of the FCPA.  Distributor further declares that
it understands that employees (including physicians and administrators) of
non-profit, public or state-owned medical care facilities who have discretionary
spending, requisition or disbursement authority, or who supervise employees with
such authority, or who use or prescribe medical products, are likely to fall
within the FCPA’s definition of “foreign official,” and should be considered
“foreign officials” for purposes of compliance with the FCPA and this Article of
the Agreement.

Specifically, Distributor hereby certifies that it has not paid, nor offered or
agreed to pay, nor has caused to be paid, or offered or agreed to be paid,
directly or indirectly, in respect of this Agreement, any  fees, commissions or
political contributions to any  “foreign official” anywhere for the purpose of
influencing such official’s act or decision to provide business to Distributor
or to Micrus.  Distributor further certifies that it will not, directly or
indirectly, in connection with this Agreement and the business resulting there
from, offer, pay, promise to pay, or authorize the giving of money or anything
of value to any public or governmental employee or official, to any political
party or official thereof or to any candidate for political office, or to any
other person or entity if it is likely that all or a portion of such money or
thing of value will be offered, given or promised, directly or indirectly, to
any “foreign official,”

 

 
6

--------------------------------------------------------------------------------

 

 to any political party or official thereof, or to any candidate to political
office, for the purpose of:  (a) influencing any act or decision of such
official, political party, party official, or candidate in his or its official
capacity, including a decision to fail to perform his or its official functions;
or (b) inducing such official, political party, party official or candidate to
use his or its influence with the government or instrumentality thereof to
affect or influence any act or decision of such government or instrumentality,
in order to assist Micrus or Distributor in obtaining or retaining business for
or with, or directing business to any third party.  Distributor further
certifies that it will not, directly or indirectly, in connection with this
Agreement and the business resulting there from, offer, pay, promise to pay, or
authorize the giving of money or anything of value to any person, while knowing
or being aware of a high probability that all or a portion of such money or
thing of value will be offered, given, or promised, directly or indirectly, to
any “foreign official,” to any foreign political party or official thereof, or
to any candidate for foreign political office, for the purpose of:   (a)
influencing any act or decision of such official, political party, party
official, or candidate in his or its official capacity, including a decision to
fail to perform his or its official functions; or (b) inducing such official,
political party, party official or candidate to use his or its influence with
the government or instrumentality thereof to affect or influence any act or
decision of such government or instrumentality, in order to assist Micrus or
Distributor in obtaining or retaining business for or with, or directing
business to any third party.

Distributor agrees that it shall make its books and records available to Micrus
for inspection upon Micrus’ request so that Micrus can ensure that Distributor
has devised and maintained a system of internal accounting controls sufficient
to provide reasonable assurances, upon request from Micrus, that (a)
Distributor’s accounts accurately and fairly reflect, in reasonable detail,
Distributor’s transactions and dispositions of cash; (b) all transactions are
executed with general or specific authorization from]; (c) transactions are
recorded as necessary to maintain accountability for assets; (d) access to
assets is permitted only in accordance with  general or specific authorization
of Distributor’s  Managing Director for Healthcare; and (e) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences.   Distributor will also comply with any request to review its books
and records with respect to one or more specific transactions about which Micrus
may inquire in its reasonable discretion, and to cooperate with any review of
such transaction(s), and will provide such other documents and information
(including, without limitation, information relating to subdistributors)
reasonably requested by Micrus to ensure compliance by Distributor of its
obligations under this Agreement and with the provisions of applicable law.

Distributor also agrees that it will require that all of its officers, employees
and contractors (if any are specifically approved by Micrus in writing pursuant
to Section 2.1 of this Agreement), who do or will assist, directly or
indirectly, Distributor in the promotion and sale of the Products pursuant to
this Agreement, complete initial training to ensure that they understand and
agree to comply with the provisions of the FCPA and this Section 5.5 as well as
a code of ethical business conduct satisfactory to Micrus in its sole
discretion.  Distributor will further require that all officers, employees and
distributors will complete further training to ensure compliance with the FCPA
and this Section 5.5 no less frequently than on an annual basis.  Distributor
will, on request, provide Micrus with signed certifications from all officers,
employees and contractors, confirming that each such officer, employee and
contractor has completed the required training and is in compliance with the
FCPA, this Section 5.5, and the applicable code of conduct.  Further,
Distributor will provide Micrus, at least ten (10) business days in advance of
such training, with copies of the training materials to be delivered to
Distributor’s officers, employees and contractors for Micrus’ review and
approval.  Distributor also agrees to record, by audio- and/or video- means,
each training session delivered to its officers, employees and contractors, to
maintain such recordings for a period of not less than three (3) years, and to
provide such recordings to Micrus upon request.

Distributor further agrees that if subsequent developments cause the
certifications and information reported herein to be no longer accurate or
complete, Distributor will immediately so advise Micrus.  Distributor further
agrees that its violation of any part of this Section 5.5, including any refusal
to make its books and records available for Micrus’s inspection, or any actual
suspected violation of law or of the applicable code of conduct, will be a
material breach of this Agreement and cause for immediate termination, without
further liability or obligation on the part of Micrus notwithstanding anything
to the contrary provided in this Agreement.

Distributor shall obtain and bear all expenses relating to any necessary
licenses and/or exemptions with respect to the export from the United States of
the Products to any location in compliance with all applicable laws and
regulations.

5.6   Traceability. Distributor agrees to maintain access to records allowing
Micrus the ability to determine all customers who were shipped specific product
lots. Product Identification and traceability requirements are defined in ISO
9001 : 1994 (E) requirement 4.8 as : “…the supplier shall maintain documented
procedures for identifying the product from production, delivery and
installation.” Traceability in ISO 8402 Vocabulary is defined as : “ability to
trace the distribution and location of the product after delivery”.

 

 
7

--------------------------------------------------------------------------------

 

ARTICLE VI - FAILURE TO MEET MINIMUM
REQUIREMENTS

In the event that in any given year, the total Product orders and payments by
Distributor under Section 3.6 do not, in the aggregate, equal or exceed: the
minimum annual purchase requirements in the amounts set forth in Exhibit B
hereto ("Minimum Purchase Requirements"), then Micrus may, at its sole
discretion, either: (a) convert the grant of the distribution rights pursuant to
Section 2.1 hereof to a non-exclusive basis; or (b) terminate this Agreement
upon (120) days prior written notice to Distributor. If Micrus elects to convert
the grant of distribution rights to a non-exclusive basis, such election shall
be made by delivery of written notice by Micrus to Distributor and shall take
effect on the date set forth in the notice, and Micrus will in that event retain
the right thereafter to terminate this Agreement if at any time Distributor
again fails to equal or exceed the Minimum Purchase Requirements.

ARTICLE VII - CONFIDENTIAL INFORMATION

The parties hereto agree that each shall keep completely confidential and shall
not publish or otherwise divulge or use for its own benefit or for the benefit
of any third party any information of a proprietary nature furnished to it (the
"Receiving Party") by the other party (the "Disclosing Party") for a period of
five (5) years after the termination of this Agreement without the prior written
approval of the Disclosing Party in each instance, except to the extent that it
is necessary to divulge such information for the obtaining of governmental
approval for the marketing of the Products and the Receiving Party discloses
only the minimum of information necessary in connection therewith and takes
reasonable steps to maintain the confidentiality of such information. Nothing in
this Article VII shall prevent disclosure or use of information: (i) already
known to the Receiving Party prior to its receipt of such information from the
Disclosing Party; (ii) which was known to the public at the time of disclosure,
or subsequently becomes so known through no act or omission of the Receiving
Party; (iii) which is properly acquired by the Receiving Party from a third
party having the right to convey such information; or (iv) that is required to
be disclosed by law or regulation or in connection with any financing,
acquisition, merger or sale, provided the Receiving Party provides the
Disclosing Party with advance notice of such disclosure and takes reasonable
steps to protect the confidentiality of such information. Information of a
proprietary nature shall include, but not be limited to, information concerning
a party's products, proposed products, marketing plans, methods of manufacture,
customers or any other information or materials in whatever form not generally
known to the public. Subject to the foregoing, this specific terms of this
Agreement (including all financial terms) shall be kept confidential, however,
the parties may refer generally to this Agreement and the parties' relationship
arising therefrom.

ARTICLE VIII - WARRANTY; LIMITATION OF LIABILITY

8.1   Warranty. Micrus represents and warrants to Distributor that all Products
manufactured and delivered to Distributor pursuant to this Agreement shall meet
Micrus' specifications for such Products at the time of delivery by Micrus to
Distributor for the shelf life of the Product as specified on the Product
labeling; provided, however, that such Product: (i) has been shipped in
accordance with Micrus' shipping instructions and stored in accordance with the
instructions on the labeling and the packaging for such Product; (ii) is used in
the application for which it was intended; and (iii) has not been modified
without Micrus' prior written consent. Distributor shall handle and be solely
responsible for all warranty returns from its direct and indirect customers.
MICRUS' SOLE AND EXCLUSIVE LIABILITY UNDER THE WARRANTY SET FORTH IN THIS
SECTION 8.1 SHALL BE LIMITED TO A REPLACEMENT TO DISTRIBUTOR OF THE DEFECTIVE
UNIT OF THE PRODUCT WITH A PRODUCT UNIT SUBSTANTIALLY EQUIVALENT TO THE UNIT
ORIGINALLY SHIPPED BY MICRUS TO DISTRIBUTOR, OR IF THAT IS IMPRACTICABLE, THE
REFUND BY MICRUS TO DISTRIBUTOR OF ALL AMOUNTS PAID TO MICRUS FOR SUCH DEFECTIVE
UNIT.

8.2       No Other Warranty. EXCEPT FOR THE EXPRESS WARRANTY SET FORTH IN
SECTION 8.1 HEREIN, THE PRODUCT IS PROVIDED "AS IS," AND MICRUS GRANTS NO OTHER
WARRANTIES, EXPRESS OR IMPLIED, BY STATUTE OR OTHERWISE, REGARDING ANY PRODUCT,
ITS FITNESS FOR ANY PARTICULAR PURPOSE, ITS QUALITY, ITS MERCHANTABILITY, OR
OTHERWISE.

8.3       Limitation of Liability: NOTWITHSTANDING ANYTHING ELSE IN THIS
AGREEMENT OR OTHERWISE, IN NO EVENT SHALL MICRUS BE LIABLE TO DISTRIBUTOR OR ANY
OTHER PERSON OR ENTITY WITH RESPECT TO ANY SUBJECT MATTER OF THIS AGREEMENT
UNDER ANY CONTRACT, NEGLIGENCE, STRICT LIABILITY OR OTHER LEGAL OR EQUITABLE
THEORY FOR (A) THE COST OF PROCUREMENT OF SUBSTITUTE GOODS,

 

 
8

--------------------------------------------------------------------------------

 

(B) ANY SPECIAL, CONSEQUENTIAL, PUNITIVE. INDIRECT OR INCIDENTAL DAMAGES OR (C)
LOST PROFITS OR LOST BUSINESS; EVEN IF THE REMEDIES PROVIDED FOR IN THIS
AGREEMENT FAIL OF THEIR ESSENTIAL PURPOSE AND EVEN IF EITHER PARTY HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES; PROVIDED, HOWEVER, THAT NOTHING
HEREIN SHALL RELIEVE MICRUS FROM ANY PRODUCT LIABILITY CLAIM, AS SET FORTH IN
ARTICLE IX HERETO.

8.4   Ownership. Distributor acknowledges and agrees that as between Distributor
and Micrus, Micrus owns all right, title and interest in and to all clinical,
technical, product, sales, marketing, and customer information and data with
respect to the Products (including, without limitation, any and all
modifications, design changes or improvements relating thereto), and all
industrial and intellectual property rights of any kind in relation to the
Products (including, without limitation, any and all modifications, design
changes or improvements relating thereto) or any of the foregoing, including,
without limitation, the right to patents, registered or other designs,
trademarks, trade names, inventions, copyright, know-how and any other
confidential information. Nothing contained in this Agreement shall be effective
to give Distributor any rights of ownership in or to any of the foregoing. To
the extent Distributor owns any rights, title or interest in or to the
foregoing, Distributor hereby assigns all of such rights to Micrus. The
provision of Product technical information to Distributor under this Agreement
is for the sole purpose of obtaining approval from the regulatory authorities in
the Territory for the Products and is subject to the confidentiality obligations
set forth in Article VII. The use by Distributor of any of these property rights
is authorized only for the purposes herein set forth, and upon termination of
this Agreement for any reason such authorization shall cease.

8.5   Sale Conveys No Right to Manufacture or Copy. The Products are offered for
sale and is sold by Micrus subject in every case to the condition that such sale
does not convey any license, expressly or by implication, to manufacture,
duplicate or otherwise copy or reproduce any Product or any portion thereof.
Distributor shall take appropriate steps with its customers and distributors, if
any, as Micrus may request, to inform them of and assure compliance with the
restrictions contained in this Section 8.5.

ARTICLE IX - INDEMNIFICATION

9.1   Indemnification by Micrus. Micrus agrees to and hereby does indemnify and
hold Distributor harmless from and against all claims, damages, losses, costs
and expenses, including reasonable attorneys' fees, which Distributor may incur
by reason of any Product sold or furnished by Micrus which result in injury,
illness, or death of any person, to the extent that such claims arise out of or
result from either the negligence or willful misconduct of Micrus in: (i)
product design; or (ii) manufacturing; or (iii) breach of any representations or
warranties by Micrus hereunder, except if such claims arise from the negligence
or willful misconduct of Distributor, any modification of the Product other than
by Micrus or any breach by Distributor of any of its obligations,
representations or warranties under this Agreement. Micrus shall have sole
control of any such action or settlement negotiations, and Micrus agrees to pay,
subject to the limitations hereinafter set forth, any final judgment entered
against Distributor or its customer on such issue in any such suit or
proceedings indemnified hereunder by Micrus. Distributor agrees to notify Micrus
promptly in writing of such claim, suit or proceeding and gives Micrus authority
to proceed as contemplated herein, and, at Micrus' expense, give Micrus proper
and full information and assistance to settle and/or defend any such claim, suit
or proceeding. If the Product, or any part thereof, is the subject of any claim,
suit or proceeding for infringement of any third party patents or trademark in
the United States or in the Territory, or if the sale or use of the Product, or
any part thereof, is, as a result thereof, enjoined, then Micrus shall, at its
option and expense: (a) procure for Distributor and its customers the right
under such patent, or trademark to sell or use, as appropriate, the Product or
such part thereof; or (b) replace the Product, or part thereof, with other
suitable Product or parts; or (c) suitably modify the Product, or part thereof,
or (d) if the use of the Product, or part thereof, is prevented by injunction,
remove the Product or part thereof, and refund the aggregate payments paid
therefore by Distributor, less a reasonable sum for the use and damage; provided
that such claim, suit or proceeding is not based on a modification of the
Product by Distributor or anyone other than Micrus, or a combination of the
Product with any product other than those provided by Micrus for use with the
Product.

9.2   Indemnification by Distributor. Distributor hereby agrees to and hereby
does indemnify and hold Micrus harmless from and against all claims, damages,
losses, costs and expenses, including reasonable attorneys' fees, which Micrus
may incur to the extent that such claims arise out or result from; (i) the
unlawful sale or other distribution of Products by Distributor, including any
improper sales by Distributor to customers who are located outside the
Territory; (ii) the negligent or willful misconduct of Distributor in the
distribution, labeling or packaging of the Product; (iii) Distributor's
recommended use of Products in violation of this Agreement; (iv) modification of
the Product by Distributor, (v) combination of the Product with any product
other than those provided by Micrus for use with the Product, or (vi) breach of
any representation, warranty, or obligation by Distributor hereunder, except for
such claims which arise out of or result from the negligence, or willful
misconduct of Micrus. Distributor shall have sole control of any such action or
settlement negotiations, and Distributor agrees to pay, subject to the
limitations hereinafter set forth, any final judgment entered

 

 
9

--------------------------------------------------------------------------------

 

against Micrus or its customer on such issue in any such suit or proceedings
defended by Distributor. Micrus agrees to notify Distributor promptly in writing
of such claim, suit or proceeding and gives Distributor authority to proceed as
contemplated herein, and, at Distributor's expense, give Distributor proper and
full information and assistance to settle and/or defend any such claim, suit or
proceeding.

9.3   Contribution. In the event the negligence of Distributor and Micrus
contribute to any loss, cost, damages, claim or expense relating to Product
supplied and/or distributed or sold hereunder, then Distributor and Micrus shall
be responsible for that portion of the loss, cost, damages, claim or expense to
which its negligence contributed.

ARTICLE X - TERM AND TERMINATION

10.1  Term. This Agreement shall commence on the Effective Date and shall
continue in force until the fifth anniversary of the Reimbursement Date (as
defined in Exhibit B), unless terminated earlier pursuant to the provisions of
this Article X or or Article VI above.
 
10.2  Failure to Make Payment. Micrus may terminate this Agreement at any time
upon Distributor's failure to make payments due to Micrus pursuant to this
Agreement and the continuation of such failure for more than thirty (30) days
after delivery of written notice to Distributor of such failure.

10.3  Failure to Commercialize or Obtain Marketing Authorizations. Micrus may
terminate this Agreement at any time upon Distributor's failure to use diligent
efforts to move ahead with its obligations to market, sell and distribute
Products under Section 5.1 or meet the Minimum Purchase Requirement and upon the
continuation of such failure for more than ninety (90) days after delivery of
written notice to Distributor of such failure, except where such failure of
Distributor is a result of the failure of Micrus to meet its obligations as
defined in this Agreement or due to circumstances beyond the reasonable control
of Distributor pursuant to Section 11.7 hereof.

10.4  Patent. Copyright. Trademark or FCPA or Code of Conduct Violations;
Background Check.  Micrus may terminate this Agreement at any time without
notice upon Distributor's violation of Article VII or of Sections 5.5, 8.4, or
8.5 hereof.  In addition to the foregoing, Distributor acknowledges that Micrus
may undertake a background check through TRACE International.  Distributor
agrees to cooperate with such background check and to provide any requested
information to Micrus and/or TRACE International.  In addition, Distributor
acknowledges and agrees that if the results of such background check (or any
other information received by Micrus) reveal any record of dishonest or criminal
behavior or financial irregularity or impropriety on the part of Distributor or
any of its affiliates, owners or personnel, Micrus shall have the right to
immediately terminate the Distribution Agreement unless the identified
problem(s) is/are (if capable of remedy) promptly remedied to Micrus’
satisfaction.  Micrus shall have sole discretion to determine whether such
problem(s) are capable of remedy or have been remedied to Micrus’
satisfaction.  Micrus agrees to provide notice of any problem(s) within 10
business days after receiving the background check results, and failure to
provide such notice shall be deemed acceptance by Micrus of the results of the
background check.

10.5  Material Breach.  Except as set forth in Section 10.2 hereof or elsewhere
in this Agreement, either party may terminate this Agreement upon ninety (90)
days prior written notice in the event of the other party’s breach of any other
material provision of this Agreement, if such default or breach is not remedied
within ninety (90) days from the date of such notice, except where such default
or breach is due to circumstances beyond the reasonable control of the other
party pursuant to Section 11.7 hereof, or as otherwise specified in this Article
X.

10.6  Bankruptcy. If, during the term of this Agreement, either party makes an
assignment, of this Agreement or generally, for the benefit of creditors, or
becomes insolvent or seeks protection under any bankruptcy, receivership, trust
deed, creditor's arrangement or composition, or if any comparable proceeding is
instituted against the other party and is not dismissed within ninety (90) days
of such institution, then the other party may terminate this Agreement
immediately upon delivery of written notice thereof.

10.7  Control Event. In the event that Distributor sells all or substantially
all of its business or assets to which this Agreement relates to a
non-affiliate, or has more than fifty percent (50%) of its equity securities
purchased by a single purchaser who is a
non-affiliate in one transaction (a "Control Event") (whether by sale,
acquisition, merger, operation of law or otherwise), then Micrus may terminate
this Agreement with thirty (30) days prior written notice at any time after the
occurrence of the Control Event. In the event that Micrus sells all or
substantially all of its business or assets to which this Agreement relates to a
non-affiliate, or has more

 
10

--------------------------------------------------------------------------------

 

than fifty percent (50%) of its equity securities purchased by a purchaser who
is a non-affiliate in one transaction, then Micrus may terminate this Agreement
at any time, provided Micrus pays Distributor a termination fee of fifteen (15%)
of the Minimum Purchase Requirement for the year in which termination will be
effective. For purposes of this section, a non-affiliate is not a parent,
subsidiary or a subsidiary of a common parent or a successor.

10.8  Waiver. Any failure to terminate shall not be construed as a waiver by the
aggrieved party of its right to terminate for future defaults or breaches.

10.9  Effects of Termination.

10.9.1 Return of Property. Upon termination of this Agreement for any reason,
each party shall upon the request of the other party return all books, records,
documents, data, samples, parts, materials, and proprietary information which it
shall have received from the other party pursuant to this Agreement and which it
shall still have in its possession or control; provided, however, that a single
copy may be retained solely for legal archival purposes by each party, subject
to the confidentiality provisions of Article VII.
 
10.9.2 Accrued Payments. Termination of this Agreement by either party shall not
prejudice the right of either party to recover any payments for Products shipped
under this Agreement, and shall not prejudice any cause of action or claim of
either party accruing under this Agreement.

10.9.3 Marketing and Distribution Rights. Upon termination of this Agreement,
Distributor's rights to market, distribute, sell and otherwise transfer the
Product, and all other rights under this Agreement, shall immediately cease. The
parties shall undertake to negotiate in good faith a mutually acceptable
agreement to satisfy any contractual obligations of Distributor to supply the
Products to third parties, and Micrus shall supply all necessary inventory under
such agreements. Except as needed to satisfy any contractual obligations
existing as of the effective date of termination and as approved by Micrus in
writing, Distributor shall return all inventory in its possession or control to
Micrus in the same condition in which it was provided by Micrus within sixty
(60) days after termination.

10.9.4 Marketing Authorizations. Upon termination of this Agreement, Distributor
shall promptly assign or otherwise transfer to Micrus or its designees all of
Distributor's rights, title and interest in and to the Marketing Authorizations
and/or pending applications for the Product; provided, however, if such
termination does not result from a breach of this Agreement by Distributor,
Micrus shall reimburse Distributor for its costs incurred in obtaining such
Marketing Authorizations.

10.9.5 Trademark. Upon termination of this Agreement, the license to use the
Trademarks granted in Section 2.4 shall also terminate and all right, title and
interest in such Trademarks shall belong to Micrus.  Upon termination of this
Agreement, Distributor shall return or destroy all materials containing Micrus'
trademark, service mark, trade name and/or logo, including but not limited to
promotion materials, brochures, labels, packaging and/or samples.
 
10.9.6 Pending Orders. Upon termination of this Agreement, Micrus shall have the
right, at its option, to continue or terminate any order pending as of the
effective date of termination.

10.9.7 No Liability for Termination. Neither party will incur any liability
whatsoever for any damages, loss or expenses of any kind suffered or incurred by
the other party (or for any compensation to the other party) arising from or
incident to any termination of this Agreement pursuant to such party's right of
termination under this Agreement, whether or not such party is aware of any such
damages, loss or expenses.

10.10 Termination Not Sole Remedy. Termination is not the sole remedy under this
Agreement and, whether or not termination is effected, all other remedies will
remain available
 
ARTICLE XI - GENERAL PROVISIONS

11.1  Governing Law. This Agreement shall be governed by and interpreted in
accordance with the laws of the State of California and the United States of
America, as though all parties were resident of, and the contract was performed
solely in, California without reference to conflicts of laws rules thereof and
without regard to the United Nations Convention on Contracts for the
International Sale of Goods. Except as set forth in Section 11.2, the sole
jurisdiction and venue for actions relating to the subject matter of this

 

 
11

--------------------------------------------------------------------------------

 

Agreement shall be the California state and U.S. federal courts having
jurisdiction in Santa Clara County, California, and the parties hereby consent
to the jurisdiction of such courts.

11.2  Arbitration. Except for actions seeking injunctive relief, all disputes,
controversies, or differences which may arise between the parties hereto, out
of, in relation to, or in connection with this Agreement or the breach thereof,
shall be finally settled by binding arbitration in San Francisco, California,
U.S.A., in accordance with the Commercial Arbitration rules of the American
Arbitration Association then in effect by one (1) arbitrator appointed in
accordance with such Rules, by which each party hereto agrees to be bound.  The
arbitration shall be conducted in the English language. The parties further
agree to exclude any right of application or appeal to any courts and that the
arbitration award shall be final and binding on the parties, provided judgment
upon an award rendered shall be entered in any court having jurisdiction, or
application shall be made to such court for judicial acceptance of the award and
an order of enforcement, as the case may be.

11.3  Entire Agreement. This Agreement represents the entire Agreement and
understanding of the parties hereto with respect to the marketing and
distribution of the Products and the subject matter of this Agreement, and
supersedes all previous agreements and understandings related thereto, and may
only be amended or modified in writing signed by an authorized representative of
the parties hereto.

11.4  Assignment. Distributor may not assign, transfer or otherwise dispose of
any of its rights or obligations pursuant to this Agreement without the prior
written consent of Micrus except that the assignee is the affiliate of
Distributor. Such consent shall not be unreasonably withheld.  Micrus may assign
this Agreement to any affiliate or acquirer of Micrus.  In the absence of such
an assignment, any performance by a Micrus affiliate of an obligation of Micrus
hereunder shall, as between the parties, be deemed to have been rendered by
Micrus, and any notice to Distributor given by a Micrus affiliate hereunder
shall be deemed as between the parties to have been given by Micrus.  This
Agreement shall be binding on, inure to the benefit of, and be enforceable by
the parties, their respective heirs, successors and valid assigns.

11.5  Notice. All notices under this Agreement shall be in writing and shall be
deemed given on the date of delivery if sent by commercial courier (return
receipt or confirmation of delivery required and costs prepaid), electronic mail
(provided receipt is acknowledged by the recipient) or by personal delivery to
the party to receive such notices or other communications called for in this
Agreement at the following addresses (or at such other address for a party as
shall be specified by such party by like notice):

If to MICRUS:

 
MICRUS ENDOVASCULAR CORPORATION
 
 821 Fox Lane
 
San Jose, California 95131
 
Attention: President

If to DISTRIBUTOR:

 
 IDS (Hong Kong) Ltd.
 
 14/F Li Fung Plaza, 2 On Ping Street,
 
 Siu Lek Yuan, Shatin, Hong Kong
 
Attention:   Cho Wong, Managing Director, Healthcare HK & China

11.6  Limitation on Liability.  Except for breaches of Article VII, in no event
shall either party be liable to the other for incidental or consequential
damages, even if such party shall have been advised of the possibility of the
same.  This limitation will not reduce either party's obligations with respect
to damages that may be suffered by third parties and as to which an
indemnification obligation applies under Article IX.
 
11.7  Force Majeure.  Except for the obligation to make payments under this
Agreement, each of the parties hereto shall be excused from the performance of
its obligations hereunder in the event such performance is prevented by force
majeure, and such excuse shall continue for thirty (30) days after the
termination of such force majeure.  For the purposes of this Agreement, force
majeure is defined to include causes beyond the control of the parties hereto,
including without limitation, acts of God, acts,
 

 
 
12

--------------------------------------------------------------------------------

 

resolutions or laws of any government, war, war-like conditions, civil
commotion, destruction of production facilities or materials by fire, earthquake
or storm, labor disturbances, epidemic and failure of public utilities or common
carriers.
 
11.8    Publicity.  Neither party shall make any press release or other similar
public disclosure or announcement concerning this Agreement, without the prior
written consent of the non-disclosing party, which consent shall not be
unreasonably withheld, except as otherwise required by law.  Consent will be
deemed granted if no response is received from the non-Disclosing Party within
fifteen (15) days of its confirmed written request for approval from the
Disclosing Party.  Notwithstanding the foregoing, in the event such disclosure
or public announcement is required to be made on a more immediate basis in order
to comply with applicable laws, then approval will be deemed granted if no
response is received from the non-disclosing party within the timeframes
required by law; provided, however, that the Disclosing Party provides the
non-disclosing party with notice of the legally required timeframe for approval
of the disclosure at the time of providing a copy of the proposed disclosure or
announcement.
 
11.9    Survival of Rights.  All rights to payments and the provisions of
Articles I (Definitions), VII (Confidential Information), VIII (Warranty;
Limitation of Liability), IX (Indemnification), and XI (General Provisions), as
well as Sections 2.2 (Relationship of Parties), 4.5 (Reporting), 10.8 (No
Waiver), 10.9 (Effects of Termination) and 10.10 (Termination Not Sole Remedy)
shall survive the expiration or termination of this Agreement.
 
11.10  Legal Expenses.  The prevailing party in any legal action brought by one
party against the other and arising out of this Agreement shall be entitled, in
addition to any other rights and remedies it may have, to reimbursement for its
expenses, including arbitration costs and reasonable attorney's fees.

11.11  Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original and all of which shall
constitute but one and the same document.

11.12   Headings.  Headings and captions are for convenience only and are not to
be used in the interpretation of this Agreement.

11.13   Severability.  If any provision of this Agreement is held to be illegal
or unenforceable, that provision shall be limited or eliminated to the minimum
extent necessary so that this Agreement shall otherwise remain in full force and
effect.
 
11.14 Counterparts.  This Agreement may be executed in counterparts, each of
which shall be deemed an original but all of which together shall constitute one
and the same instruments.  This Agreement may be executed by facsimile with
original signatures promptly following by a method set forth in Section 11.5.
 
 

 
13

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
date first above written.

 
MICRUS ENDOVASCULAR CORPORATION
     
      BY:    /s/ John T. Kilcoyne   
 
NAME:  John T. Kilcoyne
 
TITLE:   Chief Executive Officer
         
 IDS (Hong Kong) Ltd.
 
      BY:            /s/ Cho Wong     
 
NAME:   Cho Wong
 
TITLE:    Managing Director, Healthcare HK & China

 

 
14

--------------------------------------------------------------------------------

 

EXHIBIT A

PURCHASE PRICE

As specified in Section 3.2.1 of the Amended and Restated Distribution
Agreement, the unit pricing of the product sold to Distributor is given in the
following schedule. Each unit with be packaged sterile in an individual
container and shipped to Distributor in a multi-pack shipping box.  All prices
below are in U.S. Dollars ($)  and C.I.P. Hong Kong and China.

ACCESSORIES
       
DCB
Detachment Box
 
[***]
         
CCB
Connecting Cables
 
[***]
         
COILS
       
CRC
Cerecyte - Cashmere
 
[***]
CSP
Cerecyte - Spherical
 
[***]
CHE
Cerecyte - Helipaq
 
[***]
CFS
Cerecyte - Ultipaq
 
[***]
         
PC4 10
Presidio 10 - Cerecyte
[***]
SRC
Platinum - Cashmere
 
[***]
SPH
Platinum - Spherical
 
[***]
HEL
Platinum - Helipaq
 
[***]
FSR
Platinum - Ultipaq
 
[***]
 
Total Coils
   
STENT
       
360-XXXX
Stent - VITESSE
 
[***]
         
ACCESS DEVICES
       
MST
Microcatheter - Courier / Straight
[***]
MPS
Microcatheter - Courier / Pre Shape
[***]
WST
Guidewire - Watusi
 
[***]
 
Total Access Devices
 

 
*** Confidential Treatment Requested

 
15

--------------------------------------------------------------------------------

 

EXHIBIT B

MINIMUM PURCHASE REQUIREMENTS AND SUPPORT FROM MICRUS
 
 
The following schedule sets forth Distributor's Minimum Purchase Requirements as
specified in ARTICLE VI of the Distribution Agreement. These minimums represent
the cost of Products paid for by Distributor to Micrus during each year of the
Agreement.  All amounts are in US Dollars.

TERRITORY                                           SFDA
Approval               Year 1*                     Year
2                        Year 3                        Year 4                
Year 5

Hong Kong &
China                                           [***]                      [***]*                      [***]                          [***]                         [***]                  
     [***]

Upon SFDA Approval of any Products, Distributor to order a minimum of [***]
Year 1* = The twelve-month period commencing on the date when Product is in the
National Reimbursement List of Interventional Medical Devices issued by Minister
of Health of People’s Republic of China (the “Reimbursement Date”) and ending on
the first anniversary of the Reimbursement Date..  If the time elapsing between
SFDA Approval and the Reimbursement Date is less than 12 months, the Minimum
Purchase Requirement for Year 1 will be reduced by an amount equal to  the
product of (a) twelve minus the number of full months elapsing between the SFDA
Approval Date and the Reimbursement Date and (b) [***].
Year 2 = The twelve month period commencing on the expiration of Year 1.
Year 3 = The twelve month period commencing on the expiration of Year 2
Year 4 = The twelve month period commencing on the expiration of Year 3
Year 5 = The twelve month period commencing on the expiration of  Year 4
 
In connection with the performance by Distributor of its Minimum Purchase
Requirement, Micrus agrees to provide limited marketing support to Distributor,
with details to be set forth in a separate marketing support agreement between
the parties.

*** Confidential Treatment Requested

 
16

--------------------------------------------------------------------------------

 

EXHIBIT C

 
Anti-Bribery and Books & Records Provisions of
 
The Foreign Corrupt Practices Act
 
Current through Pub. L. 105-366 (November 10, 1998)

 
UNITED STATES CODE
 
TITLE 15. COMMERCE AND TRADE
 
CHAPTER 2B--SECURITIES EXCHANGES
 
 
§ 78m. Periodical and other reports
 
 
(a) Reports by issuer of security; contents
 
 
Every issuer of a security registered pursuant to section 78l of this title
shall file with the Commission, in accordance with such rules and regulations as
the Commission may prescribe as necessary or appropriate for the proper
protection of investors and to insure fair dealing in the security--
 
 
(1) such information and documents (and such copies thereof) as the Commission
shall require to keep reasonably current the information and documents required
to be included in or filed with an application or registration statement filed
pursuant to section 78l of this title, except that the Commission may not
require the filing of any material contract wholly executed before July 1, 1962.
 
 
(2) such annual reports (and such copies thereof), certified if required by the
rules and regulations of the Commission by independent public accountants, and
such quarterly reports (and such copies thereof), as the Commission may
prescribe.
 
 
Every issuer of a security registered on a national securities exchange shall
also file a duplicate original of such information, documents, and reports with
the exchange.
 
 
(b) Form of report; books, records, and internal accounting; directives
 
 
* * *
 
(2) Every issuer which has a class of securities registered pursuant to section
78l of this title and every issuer which is required to file reports pursuant to
section 78o(d) of this title shall--
 
 
(A) make and keep books, records, and accounts, which, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of
the issuer; and
 
 
(B) devise and maintain a system of internal accounting controls sufficient to
provide reasonable assurances that--
 
 
(i) transactions are executed in accordance with management's general or
specific authorization;
 
 
(ii) transactions are recorded as necessary (I) to permit preparation of
financial statements in conformity with generally accepted accounting principles
or any other criteria applicable to such statements, and (II) to maintain
accountability for assets;
 
 
(iii) access to assets is permitted only in accordance with management's general
or specific authorization; and
 

 
 
 
17

--------------------------------------------------------------------------------

 

 
(iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any
differences.
 
(3)
(A) With respect to matters concerning the national security of the United
States, no duty or liability under paragraph (2) of this subsection shall be
imposed upon any person acting in cooperation with the head of any Federal
department or agency responsible for such matters if such act in cooperation
with such head of a department or agency was done upon the specific, written
directive of the head of such department or agency pursuant to Presidential
authority to issue such directives. Each directive issued under this paragraph
shall set forth the specific facts and circumstances with respect to which the
provisions of this paragraph are to be invoked. Each such directive shall,
unless renewed in writing, expire one year after the date of issuance.
 
(B) Each head of a Federal department or agency of the United States who issues
such a directive pursuant to this paragraph shall maintain a complete file of
all such directives and shall, on October 1 of each year, transmit a summary of
matters covered by such directives in force at any time during the previous year
to the Permanent Select Committee on Intelligence of the House of
Representatives and the Select Committee on Intelligence of the Senate.

 
(4) No criminal liability shall be imposed for failing to comply with the
requirements of paragraph (2) of this subsection except as provided in paragraph
(5) of this subsection.
 
 
(5) No person shall knowingly circumvent or knowingly fail to implement a system
of internal accounting controls or knowingly falsify any book, record, or
account described in paragraph (2).
 
 
(6) Where an issuer which has a class of securities registered pursuant to
section 78l of this title or an issuer which is required to file reports
pursuant to section 78o(d) of this title holds 50 per centum or less of the
voting power with respect to a domestic or foreign firm, the provisions of
paragraph (2) require only that the issuer proceed in good faith to use its
influence, to the extent reasonable under the issuer's circumstances, to cause
such domestic or foreign firm to devise and maintain a system of internal
accounting controls consistent with paragraph (2). Such circumstances include
the relative degree of the issuer's ownership of the domestic or foreign firm
and the laws and practices governing the business operations of the country in
which such firm is located. An issuer which demonstrates good faith efforts to
use such influence shall be conclusively presumed to have complied with the
requirements of paragraph (2).
 
 
(7) For the purpose of paragraph (2) of this subsection, the terms "reasonable
assurances" and "reasonable detail" mean such level of detail and degree of
assurance as would satisfy prudent officials in the conduct of their own
affairs.
 
 
* * *
 
 
<§ 78dd-1 [Section 30A of the Securities & Exchange Act of 1934].
 
 
Prohibited foreign trade practices by issuers
 
 
(a) Prohibition
 
 
It shall be unlawful for any issuer which has a class of securities registered
pursuant to section 78l of this title or which is required to file reports under
section 78o(d) of this title, or for any officer, director, employee, or agent
of such issuer or any stockholder thereof acting on behalf of such issuer, to
make use of the mails or any means or instrumentality of interstate commerce
corruptly in furtherance of an offer, payment, promise to pay, or authorization
of the payment of any money, or offer, gift, promise to give, or authorization
of the giving of anything of value to--
 
 
(1) any foreign official for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official in his official
capacity, (ii) inducing such foreign official to do or omit to do any act in
violation of the lawful duty of such official, or (iii) securing any improper
advantage; or
 
 
(B) inducing such foreign official to use his influence with a foreign
government or instrumentality thereof to affect or influence any act or decision
of such government or instrumentality,
 

 
 
 
18

--------------------------------------------------------------------------------

 

in order to assist such issuer in obtaining or retaining business for or with,
or directing business to, any person;
 
 
(2) any foreign political party or official thereof or any candidate for foreign
political office for purposes of--
 
 
(A) (i) influencing any act or decision of such party, official, or candidate in
its or his official capacity, (ii) inducing such party, official, or candidate
to do or omit to do an act in violation of the lawful duty of such party,
official, or candidate, or (iii) securing any improper advantage; or
 
 
(B) inducing such party, official, or candidate to use its or his influence with
a foreign government or instrumentality thereof to affect or influence any act
or decision of such government or instrumentality.
 
 
in order to assist such issuer in obtaining or retaining business for or with,
or directing business to, any person; or
 
 
(3) any person, while knowing that all or a portion of such money or thing of
value will be offered, given, or promised, directly or indirectly, to any
foreign official, to any foreign political party or official thereof, or to any
candidate for foreign political office, for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official, political
party, party official, or candidate in his or its official capacity, (ii)
inducing such foreign official, political party, party official, or candidate to
do or omit to do any act in violation of the lawful duty of such foreign
official, political party, party official, or candidate, or (iii) securing any
improper advantage; or
 
 
(B) inducing such foreign official, political party, party official, or
candidate to use his or its influence with a foreign government or
instrumentality thereof to affect or influence any act or decision of such
government or instrumentality,
 
 
in order to assist such issuer in obtaining or retaining business for or with,
or directing business to, any person.
 
 
(b) Exception for routine governmental action
 
 
Subsections (a) and (g) of this section shall not apply to any facilitating or
expediting payment to a foreign official, political party, or party official the
purpose of which is to expedite or to secure the performance of a routine
governmental action by a foreign official, political party, or party official.
 
 
(c) Affirmative defenses
 
 
It shall be an affirmative defense to actions under subsection (a) or (g) of
this section that--
 
 
(1) the payment, gift, offer, or promise of anything of value that was made, was
lawful under the written laws and regulations of the foreign official’s,
political party’s, party official’s, or candidate’s country; or
 
 
(2) the payment, gift, offer, or promise of anything of value that was made, was
a reasonable and bona fide expenditure, such as travel and lodging expenses,
incurred by or on behalf of a foreign official, party, party official, or
candidate and was directly related to--
 
 
(A) the promotion, demonstration, or explanation of products or services; or
 
 
(B) the execution or performance of a contract with a foreign government or
agency thereof.
 
 
(d) Guidelines by Attorney General
 
 
Not later than one year after August 23, 1988, the Attorney General, after
consultation with the Commission, the Secretary of Commerce, the United States
Trade Representative, the Secretary of State, and the Secretary of the Treasury,
and after obtaining the views of all interested persons through public notice
and comment procedures, shall determine to what extent compliance with this
 
 

 
19

--------------------------------------------------------------------------------

 

 
section would be enhanced and the business community would be assisted by
further clarification of the preceding provisions of this section and may, based
on such determination and to the extent necessary and appropriate, issue--
 
 
(1) guidelines describing specific types of conduct, associated with common
types of export sales arrangements and business contracts, which for purposes of
the Department of Justice’s present enforcement policy, the Attorney General
determines would be in conformance with the preceding provisions of this
section; and
 
 
(2) general precautionary procedures which issuers may use on a voluntary basis
to conform their conduct to the Department of Justice’s present enforcement
policy regarding the preceding provisions of this section.
 
 
The Attorney General shall issue the guidelines and procedures referred to in
the preceding sentence in accordance with the provisions of subchapter II of
chapter 5 of Title 5 and those guidelines and procedures shall be subject to the
provisions of chapter 7 of that title.
 
 
(e) Opinions of Attorney General
 
 
(1) The Attorney General, after consultation with appropriate departments and
agencies of the United States and after obtaining the views of all interested
persons through public notice and comment procedures, shall establish a
procedure to provide responses to specific inquiries by issuers concerning
conformance of their conduct with the Department of Justice’s present
enforcement policy regarding the preceding provisions of this section. The
Attorney General shall, within 30 days after receiving such a request, issue an
opinion in response to that request. The opinion shall state whether or not
certain specified prospective conduct would, for purposes of the Department of
Justice’s present enforcement policy, violate the preceding provisions of this
section. Additional requests for opinions may be filed with the Attorney General
regarding other specified prospective conduct that is beyond the scope of
conduct specified in previous requests. In any action brought under the
applicable provisions of this section, there shall be a rebuttable presumption
that conduct, which is specified in a request by an issuer and for which the
Attorney General has issued an opinion that such conduct is in conformity with
the Department of Justice’s present enforcement policy, is in compliance with
the preceding provisions of this section. Such a presumption may be rebutted by
a preponderance of the evidence. In considering the presumption for purposes of
this paragraph, a court shall weight all relevant factors, including but not
limited to whether the information submitted to the Attorney General was
accurate and complete and whether it was within the scope of the conduct
specified in any request received by the Attorney General. The Attorney General
shall establish the procedure required by this paragraph in accordance with the
provisions of subchapter II of chapter 5 of Title 5 and that procedure shall be
subject to the provisions of chapter 7 of that title.
 
 
(2) Any document or other material which is provided to, received by, or
prepared in the Department of Justice or any other department or agency of the
United States in connection with a request by an issuer under the procedure
established under paragraph (1), shall be exempt from disclosure under section
552 of Title 5 and shall not, except with the consent of the issuer, be made
publicly available, regardless of whether the Attorney General responds to such
a request or the issuer withdraws such request before receiving a response.
 
 
(3) Any issuer who has made a request to the Attorney General under paragraph
(1) may withdraw such request prior to the time the Attorney General issues an
opinion in response to such request. Any request so withdrawn shall have no
force or effect.
 
 
(4) The Attorney General shall, to the maximum extent practicable, provide
timely guidance concerning the Department of Justice’s present enforcement
policy with respect to the preceding provisions of this section to potential
exporters and small businesses that are unable to obtain specialized counsel on
issues pertaining to such provisions. Such guidance shall be limited to
responses to requests under paragraph (1) concerning conformity of specified
prospective conduct with the Department of Justice’s present enforcement policy
regarding the preceding provisions of this section and general explanations of
compliance responsibilities and of potential liabilities under the preceding
provisions of this section.
 

 

 
20

--------------------------------------------------------------------------------

 

 
(f) Definitions
 
 
For purposes of this section:
 
(1)
A) The term “foreign official” means any officer or employee of a foreign
government or any department, agency, or instrumentality thereof, or of a public
international organization, or any person acting in an official capacity for or
on behalf of any such government or department, agency, or instrumentality, or
for or on behalf of any such public international organization.
 
(B) For purposes of subparagraph (A), the term “public international
organization” means--

   
(i)
an organization that is designated by Executive Order pursuant to section 1 of
the International Organizations Immunities Act (22 U.S.C. § 288); or
   
(ii)
any other international organization that is designated by the President by
Executive order for the purposes of this section, effective as of the date of
publication of such order in the Federal Register.

(2)
(A) A person’s state of mind is “knowing” with respect to conduct, a
circumstance, or a result if--

   
(i)
such person is aware that such person is engaging in such conduct, that such
circumstance exists, or that such result is substantially certain to occur; or
   
(ii)
such person has a firm belief that such circumstance exists or that such result
is substantially certain to occur.

 
(B) When knowledge of the existence of a particular circumstance is required for
an offense, such knowledge is established if a person is aware of a high
probability of the existence of such circumstance, unless the person actually
believes that such circumstance does not exist.
 
(3)
(A) The term “routine governmental action” means only an action which is
ordinarily and commonly performed by a foreign official in--

 
(i) obtaining permits, licenses, or other official documents to qualify a person
to do business in a foreign country;
 
 
(ii) processing governmental papers, such as visas and work orders;
 
 
(iii) providing police protection, mail pick-up and delivery, or scheduling
inspections associated with contract performance or inspections related to
transit of goods across country;
 
 
(iv) providing phone service, power and water supply, loading and unloading
cargo, or protecting perishable products or commodities from deterioration; or
 
 
(v) actions of a similar nature.
 
 
(B) The term “routine governmental action” does not include any decision by a
foreign official whether, or on what terms, to award new business to or to
continue business with a particular party, or any action taken by a foreign
official involved in the decision-making process to encourage a decision to
award new business to or continue business with a particular party.
 
 
 
(g)       Alternative Jurisdiction

 
 
(1) It shall also be unlawful for any issuer organized under the laws of the
United States, or a State, territory, possession, or commonwealth of the United
States or a political subdivision thereof and which has a class of securities
registered pursuant to section 12 of this title or which is required to file
reports under section 15(d) of this title, or for any United States person that
is an officer, director, employee, or agent of such issuer or a stockholder
thereof acting on behalf of such issuer, to corruptly do any act outside the
United States in furtherance of an offer, payment, promise to pay, or
authorization of the payment of any money, or offer, gift, promise to give, or
authorization of the giving of anything of value to any of the persons or
entities set forth in paragraphs (1), (2), and (3) of this subsection (a) of
this section for the purposes set forth therein, irrespective of whether such
issuer or such officer, director, employee, agent, or stockholder makes use of
the mails or any means or instrumentality of interstate commerce in furtherance
of such offer, gift, payment, promise, or authorization.
 

 

 
21

--------------------------------------------------------------------------------

 
 
(2) As used in this subsection, the term “United States person” means a national
of the United States (as defined in section 101 of the Immigration and
Nationality Act (8 U.S.C. § 1101)) or any corporation, partnership, association,
joint-stock company, business trust, unincorporated organization, or sole
proprietorship organized under the laws of the United States or any State,
territory, possession, or commonwealth of the United States, or any political
subdivision thereof.
 
 
§ 78dd-2. Prohibited foreign trade practices by domestic concerns
 
 
(a) Prohibition
 
 
It shall be unlawful for any domestic concern, other than an issuer which is
subject to section 78dd-1 of this title, or for any officer, director, employee,
or agent of such domestic concern or any stockholder thereof acting on behalf of
such domestic concern, to make use of the mails or any means or instrumentality
of interstate commerce corruptly in furtherance of an offer, payment, promise to
pay, or authorization of the payment of any money, or offer, gift, promise to
give, or authorization of the giving of anything of value to--
 
 
(1) any foreign official for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official in his official
capacity, (ii) inducing such foreign official to do or omit to do any act in
violation of the lawful duty of such official, or (iii) securing any improper
advantage; or
 
 
(B) inducing such foreign official to use his influence with a foreign
government or instrumentality thereof to affect or influence any act or decision
of such government or instrumentality,
 
 
in order to assist such domestic concern in obtaining or retaining business for
or with, or directing business to, any person;
 
 
(2) any foreign political party or official thereof or any candidate for foreign
political office for purposes of--
 
 
(A) (i) influencing any act or decision of such party, official, or candidate in
its or his official capacity, (ii) inducing such party, official, or candidate
to do or omit to do an act in violation of the lawful duty of such party,
official, or candidate, or (iii) securing any improper advantage; or
 
 
(B) inducing such party, official, or candidate to use its or his influence with
a foreign government or instrumentality thereof to affect or influence any act
or decision of such government or instrumentality,
 
 
in order to assist such domestic concern in obtaining or retaining business for
or with, or directing business to, any person;
 
 
(3) any person, while knowing that all or a portion of such money or thing of
value will be offered, given, or promised, directly or indirectly, to any
foreign official, to any foreign political party or official thereof, or to any
candidate for foreign political office, for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official, political
party, party official, or candidate in his or its official capacity, (ii)
inducing such foreign official, political party, party official, or candidate to
do or omit to do any act in violation of the lawful duty of such foreign
official, political party, party official, or candidate, or (iii) securing any
improper advantage; or
 
 
(B) inducing such foreign official, political party, party official, or
candidate to use his or its influence with a foreign government or
instrumentality thereof to affect or influence any act or decision of such
government or instrumentality,
 
in order to assist such domestic concern in obtaining or retaining business for
or with, or directing business to, any person.
 
 
(b) Exception for routine governmental action
 
 
Subsections (a) and (i) of this section shall not apply to any facilitating or
expediting payment to a foreign official, political party, or party official the
purpose of which is to expedite or to secure the performance of a routine
governmental action by a foreign official, political party, or party official.
 
 
22

--------------------------------------------------------------------------------

 

 
(c) Affirmative defenses
 
 
It shall be an affirmative defense to actions under subsection (a) or (i) of
this section that--
 
 
(1) the payment, gift, offer, or promise of anything of value that was made, was
lawful under the written laws and regulations of the foreign official’s,
political party’s, party official’s, or candidate’s country; or
 
 
(2) the payment, gift, offer, or promise of anything of value that was made, was
a reasonable and bona fide expenditure, such as travel and lodging expenses,
incurred by or on behalf of a foreign official, party, party official, or
candidate and was directly related to--
 
 
(A) the promotion, demonstration, or explanation of products or services; or
 
 
(B) the execution or performance of a contract with a foreign government or
agency thereof.
 
 
(d) Injunctive relief
 
 
(1) When it appears to the Attorney General that any domestic concern to which
this section applies, or officer, director, employee, agent, or stockholder
thereof, is engaged, or about to engage, in any act or practice constituting a
violation of subsection (a) or (i) of this section, the Attorney General may, in
his discretion, bring a civil action in an appropriate district court of the
United States to enjoin such act or practice, and upon a proper showing, a
permanent injunction or a temporary restraining order shall be granted without
bond.
 
 
(2) For the purpose of any civil investigation which, in the opinion of the
Attorney General, is necessary and proper to enforce this section, the Attorney
General or his designee are empowered to administer oaths and affirmations,
subpoena witnesses, take evidence, and require the production of any books,
papers, or other documents which the Attorney General deems relevant or material
to such investigation. The attendance of witnesses and the production of
documentary evidence may be required from any place in the United States, or any
territory, possession, or commonwealth of the United States, at any designated
place of hearing.
 
 
(3) In case of contumacy by, or refusal to obey a subpoena issued to, any
person, the Attorney General may invoke the aid of any court of the United
States within the jurisdiction of which such investigation or proceeding is
carried on, or where such person resides or carries on business, in requiring
the attendance and testimony of witnesses and the production of books, papers,
or other documents. Any such court may issue an order requiring such person to
appear before the Attorney General or his designee, there to produce records, if
so ordered, or to give testimony touching the matter under investigation. Any
failure to obey such order of the court may be punished by such court as a
contempt thereof.
 
 
All process in any such case may be served in the judicial district in which
such person resides or may be found. The Attorney General may make such rules
relating to civil investigations as may be necessary or appropriate to implement
the provisions of this subsection.
 
 
(e) Guidelines by Attorney General
 
 
Not later than 6 months after August 23, 1988, the Attorney General, after
consultation with the Securities and Exchange Commission, the Secretary of
Commerce, the United States Trade Representative, the Secretary of State, and
the Secretary of the Treasury, and after obtaining the views of all interested
persons through public notice and comment procedures, shall determine to what
extent compliance with this section would be enhanced and the business community
would be assisted by further clarification of the preceding provisions of this
section and may, based on such determination and to the extent necessary and
appropriate, issue--
 
 
(1) guidelines describing specific types of conduct, associated with common
types of export sales arrangements and business contracts, which for purposes of
the Department of Justice’s present enforcement policy, the Attorney General
determines would be in conformance with the preceding provisions of this
section; and
 
 
(2) general precautionary procedures which domestic concerns may use on a
voluntary basis to conform their conduct to the Department of Justice’s present
enforcement policy regarding the preceding provisions of this section.
 

 

 
23

--------------------------------------------------------------------------------

 

 
The Attorney General shall issue the guidelines and procedures referred to in
the preceding sentence in accordance with the provisions of subchapter II of
chapter 5 of Title 5 and those guidelines and procedures shall be subject to the
provisions of chapter 7 of that title.
 
 
(f) Opinions of Attorney General
 
 
(1) The Attorney General, after consultation with appropriate departments and
agencies of the United States and after obtaining the views of all interested
persons through public notice and comment procedures, shall establish a
procedure to provide responses to specific inquiries by domestic concerns
concerning conformance of their conduct with the Department of Justice’s present
enforcement policy regarding the preceding provisions of this section. The
Attorney General shall, within 30 days after receiving such a request, issue an
opinion in response to that request. The opinion shall state whether or not
certain specified prospective conduct would, for purposes of the Department of
Justice’s present enforcement policy, violate the preceding provisions of this
section. Additional requests for opinions may be filed with the Attorney General
regarding other specified prospective conduct that is beyond the scope of
conduct specified in previous requests. In any action brought under the
applicable provisions of this section, there shall be a rebuttable presumption
that conduct, which is specified in a request by a domestic concern and for
which the Attorney General has issued an opinion that such conduct is in
conformity with the Department of Justice’s present enforcement policy, is in
compliance with the preceding provisions of this section. Such a presumption may
be rebutted by a preponderance of the evidence. In considering the presumption
for purposes of this paragraph, a court shall weigh all relevant factors,
including but not limited to whether the information submitted to the Attorney
General was accurate and complete and whether it was within the scope of the
conduct specified in any request received by the Attorney General. The Attorney
General shall establish the procedure required by this paragraph in accordance
with the provisions of subchapter II of chapter 5 of Title 5 and that procedure
shall be subject to the provisions of chapter 7 of that title.
 
 
(2) Any document or other material which is provided to, received by, or
prepared in the Department of Justice or any other department or agency of the
United States in connection with a request by a domestic concern under the
procedure established under paragraph (1), shall be exempt from disclosure under
section 552 of Title 5 and shall not, except with the consent of the domestic
concern, by made publicly available, regardless of whether the Attorney General
response to such a request or the domestic concern withdraws such request before
receiving a response.
 
 
(3) Any domestic concern who has made a request to the Attorney General under
paragraph (1) may withdraw such request prior to the time the Attorney General
issues an opinion in response to such request. Any request so withdrawn shall
have no force or effect.
 
 
(4) The Attorney General shall, to the maximum extent practicable, provide
timely guidance concerning the Department of Justice’s present enforcement
policy with respect to the preceding provisions of this section to potential
exporters and small businesses that are unable to obtain specialized counsel on
issues pertaining to such provisions. Such guidance shall be limited to
responses to requests under paragraph (1) concerning conformity of specified
prospective conduct with the Department of Justice’s present enforcement policy
regarding the preceding provisions of this section and general explanations of
compliance responsibilities and of potential liabilities under the preceding
provisions of this section.
 
 
(g) Penalties
 
(1)
(A) Any domestic concern that is not a natural person and that violates
subsection (a) or (i) of this section shall be fined not more than $2,000,000.
(B) Any domestic concern that is not a natural person and that violates
subsection (a) or (i) of this section shall be subject to a civil penalty of not
more than $10,000 imposed in an action brought by the Attorney General.
(2)
(A) Any natural person that is an officer, director, employee, or agent of a
domestic concern, or stockholder acting on behalf of such domestic concern, who
willfully violates subsection (a) or (i) of this section shall be fined not more
than $100,000 or imprisoned not more than 5 years, or both.
(B) Any natural person that is an officer, director, employee, or agent of a
domestic concern, or stockholder acting on behalf of such domestic concern, who
violates subsection (a) or (i) of this section shall be subject to a civil
penalty of not more than $10,000 imposed in an action brought by the Attorney
General.
(3)
Whenever a fine is imposed under paragraph (2) upon any officer, director,
employee, agent, or stockholder of a domestic concern, such fine may not be
paid, directly or indirectly, by such domestic concern.

 
 
 
 
 
 
24

--------------------------------------------------------------------------------

 
(h) Definitions
 
 
For purposes of this section:
 
(1)
The term "domestic concern" means--

 
(A) any individual who is a citizen, national, or resident of the United States;
and
 
 
(B) any corporation, partnership, association, joint-stock company, business
trust, unincorporated organization, or sole proprietorship which has its
principal place of business in the United States, or which is organized under
the laws of a State of the United States or a territory, possession, or
commonwealth of the United States.
 
(2)
(A) The term “foreign official” means any officer or employee of a foreign
government or any department, agency, or instrumentality thereof, or of a public
international organization, or any person acting in an official capacity for or
on behalf of any such government or department, agency, or instrumentality, or
for or on behalf of any such public international organization.
(B) For purposes of subparagraph (A), the term "public international
organization" means --

 
(i) an organization that has been designated by Executive order pursuant to
Section 1 of the International Organizations Immunities Act (22 U.S.C. § 288);
or
 
 
(ii)any other international organization that is designated by the President by
Executive order for the purposes of this section, effective as of the date of
publication of such order in the Federal Register.
 
(3)
(A) A person's state of mind is "knowing" with respect to conduct, a
circumstance, or a result if--

 
(i) such person is aware that such person is engaging in such conduct, that such
circumstance exists, or that such result is substantially certain to occur; or
 
 
(ii) such person has a firm belief that such circumstance exists or that such
result is substantially certain to occur.
 
 
(B) When knowledge of the existence of a particular circumstance is required for
an offense, such knowledge is established if a person is aware of a high
probability of the existence of such circumstance, unless the person actually
believes that such circumstance does not exist.
 
(4)
 (A) The term "routine governmental action" means only an action which is
ordinarily and commonly performed by a foreign official in--

 
(i) obtaining permits, licenses, or other official documents to qualify a person
to do business in a foreign country;
 
 
(ii) processing governmental papers, such as visas and work orders;
 
 
(iii) providing police protection, mail pick-up and delivery, or scheduling
inspections associated with contract performance or inspections related to
transit of goods across country;
 
 
(iv) providing phone service, power and water supply, loading and unloading
cargo, or protecting perishable products or commodities from deterioration; or
 
 
(v) actions of a similar nature.
 
 
(B) The term "routine governmental action" does not include any decision by a
foreign official whether, or on what terms, to award new business to or to
continue business with a particular party, or any action taken by a foreign
official involved in the decision-making process to encourage a decision to
award new business to or continue business with a particular party.
 

 

 
25

--------------------------------------------------------------------------------

 

 
(5) The term "interstate commerce" means trade, commerce, transportation, or
communication among the several States, or between any foreign country and any
State or between any State and any place or ship outside thereof, and such term
includes the intrastate use of--
 
 
(A) a telephone or other interstate means of communication, or
 
 
(B) any other interstate instrumentality.
 
 
(i) Alternative Jurisdiction
 
(1)
It shall also be unlawful for any United States person to corruptly do any act
outside the United States in furtherance of an offer, payment, promise to pay,
or authorization of the payment of any money, or offer, gift, promise to give,
or authorization of the giving of anything of value to any of the persons or
entities set forth in paragraphs (1), (2), and (3) of subsection (a), for the
purposes set forth therein, irrespective of whether such United States person
makes use of the mails or any means or instrumentality of interstate commerce in
furtherance of such offer, gift, payment, promise, or authorization.
(2)
As used in this subsection, a "United States person" means a national of the
United States (as defined in section 101 of the Immigration and Nationality Act
(8 U.S.C. § 1101)) or any corporation, partnership, association, joint-stock
company, business trust, unincorporated organization, or sole proprietorship
organized under the laws of the United States or any State, territory,
possession, or commonwealth of the United States, or any political subdivision
thereof.

 
§ 78dd-3. Prohibited foreign trade practices by persons other than issuers or
domestic concerns
 
 
(a) Prohibition
 
 
It shall be unlawful for any person other than an issuer that is subject to
section 30A of the Securities Exchange Act of 1934 or a domestic concern, as
defined in section 104 of this Act), or for any officer, director, employee, or
agent of such person or any stockholder thereof acting on behalf of such person,
while in the territory of the United States, corruptly to make use of the mails
or any means or instrumentality of interstate commerce or to do any other act in
furtherance of an offer, payment, promise to pay, or authorization of the
payment of any money, or offer, gift, promise to give, or authorization of the
giving of anything of value to--
 
 
(1) any foreign official for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official in his official
capacity, (ii) inducing such foreign official to do or omit to do any act in
violation of the lawful duty of such official, or (iii) securing any improper
advantage; or
 
 
(B) inducing such foreign official to use his influence with a foreign
government or instrumentality thereof to affect or influence any act or decision
of such government or instrumentality,
 
 
in order to assist such person in obtaining or retaining business for or with,
or directing business to, any person;
 
 
(2) any foreign political party or official thereof or any candidate for foreign
political office for purposes of--
 
 
(A) (i) influencing any act or decision of such party, official, or candidate in
its or his official capacity, (ii) inducing such party, official, or candidate
to do or omit to do an act in violation of the lawful duty of such party,
official, or candidate, or (iii) securing any improper advantage; or
 
 
(B) inducing such party, official, or candidate to use its or his influence with
a foreign government or instrumentality thereof to affect or influence any act
or decision of such government or instrumentality.
 
 
in order to assist such person in obtaining or retaining business for or with,
or directing business to, any person; or
 

 

 
26

--------------------------------------------------------------------------------

 

 
(3) any person, while knowing that all or a portion of such money or thing of
value will be offered, given, or promised, directly or indirectly, to any
foreign official, to any foreign political party or official thereof, or to any
candidate for foreign political office, for purposes of--
 
 
(A) (i) influencing any act or decision of such foreign official, political
party, party official, or candidate in his or its official capacity, (ii)
inducing such foreign official, political party, party official, or candidate to
do or omit to do any act in violation of the lawful duty of such foreign
official, political party, party official, or candidate, or (iii) securing any
improper advantage; or
 
 
(B) inducing such foreign official, political party, party official, or
candidate to use his or its influence with a foreign government or
instrumentality thereof to affect or influence any act or decision of such
government or instrumentality,
 
 
in order to assist such person in obtaining or retaining business for or with,
or directing business to, any person.
 
 
(b) Exception for routine governmental action
 
 
Subsection (a) of this section shall not apply to any facilitating or expediting
payment to a foreign official, political party, or party official the purpose of
which is to expedite or to secure the performance of a routine governmental
action by a foreign official, political party, or party official.
 
 
(c) Affirmative defenses
 
 
It shall be an affirmative defense to actions under subsection (a) of this
section that--
 
 
(1) the payment, gift, offer, or promise of anything of value that was made, was
lawful under the written laws and regulations of the foreign official's,
political party's, party official's, or candidate's country; or
 
 
(2) the payment, gift, offer, or promise of anything of value that was made, was
a reasonable and bona fide expenditure, such as travel and lodging expenses,
incurred by or on behalf of a foreign official, party, party official, or
candidate and was directly related to--
 
 
(A) the promotion, demonstration, or explanation of products or services; or
 
 
(B) the execution or performance of a contract with a foreign government or
agency thereof.
 
 
(d) Injunctive relief
 
 
(1) When it appears to the Attorney General that any person to which this
section applies, or officer, director, employee, agent, or stockholder thereof,
is engaged, or about to engage, in any act or practice constituting a violation
of subsection (a) of this section, the Attorney General may, in his discretion,
bring a civil action in an appropriate district court of the United States to
enjoin such act or practice, and upon a proper showing, a permanent injunction
or a temporary restraining order shall be granted without bond.
 
 
(2) For the purpose of any civil investigation which, in the opinion of the
Attorney General, is necessary and proper to enforce this section, the Attorney
General or his designee are empowered to administer oaths and affirmations,
subpoena witnesses, take evidence, and require the production of any books,
papers, or other documents which the Attorney General deems relevant or material
to such investigation. The attendance of witnesses and the production of
documentary evidence may be required from any place in the United States, or any
territory, possession, or commonwealth of the United States, at any designated
place of hearing.
 
 
(3) In case of contumacy by, or refusal to obey a subpoena issued to, any
person, the Attorney General may invoke the aid of any court of the United
States within the jurisdiction of which such investigation or proceeding is
carried on, or where such person resides or carries on business, in requiring
the attendance and testimony of witnesses and the production of books, papers,
or other documents. Any such court may issue an order requiring such person to
appear before the Attorney General or his designee, there to produce records, if
so ordered, or to give testimony touching the matter under investigation. Any
failure to obey such order of the court may be
 

 

 
27

--------------------------------------------------------------------------------

 

 
punished by such court as a contempt thereof.
 
 
(4) All process in any such case may be served in the judicial district in which
such person resides or may be found. The Attorney General may make such rules
relating to civil investigations as may be necessary or appropriate to implement
the provisions of this subsection.
 
 
(e) Penalties
 
(1)
(A) Any juridical person that violates subsection (a) of this section shall be
fined not more than $2,000,000.
(B) Any juridical person that violates subsection (a) of this section shall be
subject to a civil penalty of not more than $10,000 imposed in an action brought
by the Attorney General.
 
(2) 
(A) Any natural person who willfully violates subsection (a) of this section
shall be fined not more than $100,000 or imprisoned not more than 5 years, or
both.
(B) Any natural person who violates subsection (a) of this section shall be
subject to a civil penalty of not more than $10,000 imposed in an action brought
by the Attorney General.
(3)
Whenever a fine is imposed under paragraph (2) upon any officer, director,
employee, agent, or stockholder of a person, such fine may not be paid, directly
or indirectly, by such person.

 
(f) Definitions
 
 
For purposes of this section:
 
(1)
The term “person,” when referring to an offender, means any natural person other
than a. national of the United States (as defined in 8 U.S.C. § 1101) or any
corporation, partnership, association, joint-stock company, business trust,
unincorporated organization, or sole proprietorship organized under the law of a
foreign nation or a political subdivision thereof
(2)
(A) The term “foreign official” means any officer or employee of a foreign
government or any department, agency, or instrumentality thereof, or of a public
international organization, or any person acting in an official capacity for or
on behalf of any such government or department, agency, or instrumentality, or
for or on behalf of any such public international organization.
For purposes of subparagraph (A), the term "public international organization"
means --

   
(i)
an organization that has been designated by Executive Order pursuant to Section
1 of the International Organizations Immunities Act (22 U.S.C. § 288); or
 
   
(ii)
any other international organization that is designated by the President by
Executive order for the purposes of this section, effective as of the date of
publication of such order in the Federal Register.

(3)
(A) A person’s state of mind is "knowing" with respect to conduct, a
circumstance, or a result if --

   
(i)
such person is aware that such person is engaging in such conduct, that such
circumstance exists, or that such result is substantially certain to occur; or
   
(ii)
such person has a firm belief that such circumstance exists or that such result
is substantially certain to occur.

 
(B) When knowledge of the existence of a particular circumstance is required for
an offense, such knowledge is established if a person is aware of a high
probability of the existence of such circumstance, unless the person actually
believes that such circumstance does not exist.
 
(4)
 (A) The term "routine governmental action" means only an action which is
ordinarily and commonly performed by a foreign official in--

   
(i)
obtaining permits, licenses, or other official documents to qualify a person to
do business in a foreign country;
 
   
(ii)
processing governmental papers, such as visas and work orders;
 
   
(iii)
providing police protection, mail pick-up and delivery, or scheduling
inspections associated with contract performance or inspections related to
transit of goods across country;
 
   
(iv) 
providing phone service, power and water supply, loading and unloading cargo, or
protecting perishable products or commodities from deterioration; or
   
(v)
actions of a similar nature.

 
(B) The term “routine governmental action” does not include any decision by a
foreign official whether, or on what terms, to award new business to or to
continue business with a particular party, or any action taken by a foreign
official involved in the decision-making process to encourage a decision to
award new business to or continue business with a particular party.
 
 
28

--------------------------------------------------------------------------------

 
(5) The term “interstate commerce” means trade, commerce, transportation, or
communication among the several States, or between any foreign country and any
State or between any State and any place or ship outside thereof, and such term
includes the intrastate use of —
 
 
(A) a telephone or other interstate means of communication, or
 
 
(B) any other interstate instrumentality.
 
 
§ 78ff. Penalties
 
 
(a) Willful violations; false and misleading statements
 
 
Any person who willfully violates any provision of this chapter (other than
section 78dd-1 of this title), or any rule or regulation thereunder the
violation of which is made unlawful or the observance of which is required under
the terms of this chapter, or any person who willfully and knowingly makes, or
causes to be made, any statement in any application, report, or document
required to be filed under this chapter or any rule or regulation thereunder or
any undertaking contained in a registration statement as provided in subsection
(d) of section 78o of this title, or by any self-regulatory organization in
connection with an application for membership or participation therein or to
become associated with a member thereof, which statement was false or misleading
with respect to any material fact, shall upon conviction be fined not more than
$5,000,000, or imprisoned not more than 20 years, or both, except that when such
person is a person other than a natural person, a fine not exceeding $25,000,000
may be imposed; but no person shall be subject to imprisonment under this
section for the violation of any rule or regulation if he proves that he had no
knowledge of such rule or regulation.
 
 
(b) Failure to file information, documents, or reports
 
 
Any issuer which fails to file information, documents, or reports required to be
filed under subsection (d) of section 78o of this title or any rule or
regulation thereunder shall forfeit to the United States the sum of $100 for
each and every day such failure to file shall continue. Such forfeiture, which
shall be in lieu of any criminal penalty for such failure to file which might be
deemed to arise under subsection (a) of this section, shall be payable into the
Treasury of the United States and shall be recoverable in a civil suit in the
name of the United States.
 
 
(c) Violations by issuers, officers, directors, stockholders, employees, or
agents of issuers

(1)
(A) Any issuer that violates subsection (a) or (g) of section 30A of this title
[15 U.S.C. § 78dd-1] shall be fined not more than $2,000,000.
(B) Any issuer that violates subsection (a) or (g) of section 30A of this title
[15 U.S.C. § 78dd-1] shall be subject to a civil penalty of not more than
$10,000 imposed in an action brought by the Commission.
(2)
(A) Any officer, director, employee, or agent of an issuer, or stockholder
acting on behalf of such issuer, who willfully violates subsection (a) or (g) of
section 30A of this title [15 U.S.C. § 78dd-1] shall be fined not more than
$100,000, or imprisoned not more than 5 years, or both.
(B) Any officer, director, employee, or agent of an issuer, or stockholder
acting on behalf of such issuer, who violates subsection (a) or (g) of section
30A of this title [15 U.S.C. § 78dd-1] shall be subject to a civil penalty of
not more than $10,000 imposed in an action brought by the Commission.

 
(3) Whenever a fine is imposed under paragraph (2) upon any officer, director,
employee, agent, or stockholder of an issuer, such fine may not be paid,
directly or indirectly, by such issuer.

 

 
29

--------------------------------------------------------------------------------